A poptosis is a complex, tightly regulated, and evolutionarily conserved mode of cell death. When cells are infected by certain viruses, apoptosis is triggered. However, many viruses are able to block apoptosis (reviewed by Miles et al. 1 ). This mechanism is thought to be one by which a virus avoids the immune system, as cytotoxic T and natural killer cells actively target apoptotic cells-a process essential in viral clearance. 1 The general molecular pathway of apoptosis is divided into an intrinsic and extrinsic arm. 1, 2 The intrinsic pathway is initiated in the mitochondria by triggers such as hypoxia or UV irradiation. 1 This action stimulates cysteine aspartate protease (caspase) recruiting domains, leading to activation of caspase 9, 3 usually followed by activation of downstream caspases, such as caspases 3, 6 , and 7, resulting in cleavage of several death substrates 4, 5 and subsequent DNA condensation and fragmentation, indicating terminal apoptosis.
Initiation of the extrinsic apoptotic pathway begins with binding of ligands such as tumor necrosis factor-␣, Fas ligand, and viruses to cell surface receptors. 3, 6 A subsequent tyrosine phosphorylation cascade stimulates various death domains in the cytoplasmic domains of these receptors. 7 These trigger the activation of caspase 8. 3, 4 At this point, the two pathways merge and initiation of downstream caspases follows. 4 Recent evidence has demonstrated that cells can be rescued from apoptosis induced by external agents in the presence [7] [8] [9] [10] [11] [12] [13] [14] or absence 15, 16 of herpes simplex viruses. Herpes simplex virus (HSV)-1 infection of the cornea remains a major cause of vision loss worldwide, despite the availability of antiviral drugs. 17 The effects of HSV-1 infection on apoptosis have been studied, mainly in liver and kidney epithelial cells, where results suggest that HSV-1 infection can prevent the induction of apoptosis when cells are exposed to exogenous proapoptotic agents (e.g., sorbitol). 10, 11, 18 However, when protein synthesis in these cells is inhibited, cells infected with HSV-1 also undergo apoptosis. This suggests that HSV-1 proteins block apoptotic pathways. [7] [8] [9] [10] [11] [12] [13] [14] Not all cell types have the same apoptotic responses to HSV-1 infection. For example, HEp-2 cells initially have a proapoptotic response followed by blockage of the apoptotic pathway, whereas Vero cells (African green monkey kidney cells) show no or a reduced apoptotic response over 24 hours. 7 In corneal epithelial cells, apoptosis has been shown to play a role in the pathogenesis of HSV keratitis; however, the apoptotic response of the cells to infection with this virus is not well characterized and cannot be inferred from data in other cell types. 19 As such, we have recently demonstrated a rapid direct activation of elements of the proapoptotic pathway by HSV during infection in human corneal epithelial (HCE) cells via caspase 8. 20 The purpose of the current investigation was to characterize the induction of early apoptotic events during infection of HCE cells by HSV-1 and to examine the ability of the virus to act subsequently to suppress the proapoptotic pathway.
the Sydney Eye Hospital in accordance with the Declaration of Helsinki and explanted on tissue culture plates in medium with human corneal growth supplement (Epilife; Cascade Biologics, Inc., Portland, OR) and calcium chloride (4 mg/mL). The cells were seeded at 92,000/cm 2 and incubated at 37°C in a 5% CO 2 -95% air incubator. Medium was exchanged on alternate days. Experiments were performed when cells were at 90% confluence. The number of cells was estimated by using trypan blue staining.
Virus and Titration Method
The HSV-1 virus strain MacIntyre (lot VR-539) was obtained from the American Type Culture Collection (ATCC, Manassas, VA). The McKrae HSV-1 strain and the laboratory-adapted KOS1.1 HSV-1 strain were the kind gift of James Hill (Louisiana State University Health and Science Center, New Orleans, LA). These HSV-1 strains were used to test whether viral strain specificity occurred in our system. All other experiments were performed with the MacIntyre HSV-1 strain. The plaque-forming assay method was used to titer the virus. Vero cells (Cascade Biologics, Inc. Portland, OR) were grown to confluence. Serial 10-fold dilutions of each virus were made in chilled maintenance medium (MEM; 1% vol/vol FBS). Culture medium (DMEM; 10% vol/vol FBS) was aspirated from the Vero cells, and 0.2 mL of viral inoculum was added. The infected cells were incubated for 1 hour at 37°C with intermittent rocking. The inoculum was removed and 1:1 vol/vol ratio of concentrated culture medium (2ϫ) and carboxymethylcellulose (0.5% wt/vol solution) was added. A multiplicity of infection (MOI) of 2 was used in all experiments, as it was determined to be the viral titer that produced the greatest response (data not shown). Plates were incubated at 37°C in a 5% CO 2 -95% air incubator, and enumeration of plaques was performed with a Stuart colony counter (model S35; Barloworld Scientific, Stone, UK) on the fourth day.
HSV-1 Infection and Sorbitol Treatment of HCE Cells
Viruses were added to HCE in MEM with 1% vol/vol FBS at a ratio of 2:1 and allowed to attach to the cells for 30 minutes. Initial HSV-1 infection of HCE cells was confirmed by immunofluorescence using HSV-1-specific polyclonal antibodies to HSV-1 glycoproteins (Dako, Carpinteria, CA). Approximately 95% of transformed HCE cells were infected when an MOI of 2 was used with each of the HSV strains. After 30 minutes, unattached virus was aspirated and fresh SHEM was added. Uninfected (mock infected) HCE cells were used as a negative control. After the attachment period, cells were collected at 0.5, 1, 2, 4, 8, and 12 hours. These cells were suspended by the addition of trypsin. The trypsin was neutralized by the addition of SHEM (containing 5% vol/vol FBS) at a ratio of 2:1 media/trypsin volume, and HCE cells were collected by centrifugation at 300g for 5 minutes. The HCE cells were either stained with apoptotic fluorescent stains or lysed for caspase quantification.
Apoptosis by osmotic shock was induced by sorbitol, as previously described. 21 Briefly, media were aspirated, and sorbitol (1.5 moles/L) in MEM was added to the cells and incubated for 1 hour at ambient temperature. The sorbitol was removed and fresh media were added. Cells were collected for assay as described earlier.
Fluorescence Staining and Microscopy
Commercially available fluorescent stains were used to assess early (mitochondrial membrane potential, annexin V, and cytokeratin 18) and late (DNA condensation) apoptotic changes in total cell populations of sorbitol-treated, HSV-1-infected and uninfected cells over time. Stained cells were quantified using fluorescence microscopy (BH 2-RFC; Olympus, Tokyo, Japan) by a masked observer. For calculation of the percentage of cells showing apoptotic changes in all staining procedures, a minimum of 500 cells were counted at each time point in triplicate preparations.
Mitochondrial Transmembrane Potential Staining.
This stain detects the changes in the mitochondrial transmembrane potential of cells. Staining was performed according to the manufacturer's protocol (BioVision, Firenze, Italy). Briefly, the cationic dye, 5,5Ј,6,6Ј-tetrachloro-1,1Ј,3,3Ј-tetraethylbenzamidazolo-carbocyanin iodide was added to the pelleted cell sample and allowed to incubate at ambient temperature for 15 minutes. Cells were washed with phosphate-buffered saline (PBS) twice and mounted on slides. A fluorescence microscope was used with a band-pass filter to detect FITC and rhodamine. The number of stained cells was counted and recorded as a percentage of the total cell population.
Annexin V Staining and Flow Cytometry. This assay detects phosphatidylserine translocation from the inner to the outer leaflet of the cell membrane. 22, 23 Assays were performed according to the manufacturer's protocol (MBL, Nagoya, Japan). Briefly, annexin V-FITC (binds to phosphatidylserine) and propidium iodide (PI, counterstain for DNA) were added to the pelleted HCE cells (approximately 10 6 cells per sample) and allowed to incubate at ambient temperature for 10 minutes. Any PI-positive cells were considered necrotic and not apoptotic. PHCE cells, stained with annexin V, were manually counted and the results recorded as the percentage of stained cells within the total cell population, whereas transformed HCE cells were analyzed by flow cytometry (Mo Flo MLS; Cytomation, Fort Collins, CO, with Cytomation Summit software version 3.1). For flow cytometry, cells were detected with FITC signal detector (excitation, 488 nm; emission, 530 nm) and PI staining by the phycoerythrin emission signal detector. Samples were gated by using a negative control (unstained viable cells in culture) and a positive control (HCE cells treated with ethanol for 1 hour, which stain with both FITC and PI). DNA Condensation. DNA condensation was detected by using the intercalating agent bis-benzimide (Hoechst 33528; Hoechst, Frankfurt, Germany), from a method modified from that of Lam et al. 24 Briefly, a stock solution (10 g/mL) of bis-benzimide was prepared using ultrapure water (milli-Q; Millipore, Bedford, MA). Approximately 10 6 cells were collected at various time points, washed with PBS (pH 7.2), and fixed in 100 L of 70% vol/vol ethanol. The cells were stained with bis-benzimide for 10 minutes at room temperature and counted. The number of stained cells was counted and recorded as a percentage of the total cell population.
Caspase Activity Assays
Assays for caspase 3, 8, and 9 were performed according to the manufacturer's protocol using the recommended controls (R&D Systems, Minneapolis, MN). Data were normalized and expressed as percentage of activity of the cell population with the highest activity (i.e., for caspase 8 [ Fig. 1 ], the activity in the HSV-1-infected cell population was taken as 100% and activity in other cell populations expressed relative to this population).
Caspase Inhibition Assays
Caspases 8 and 9 were inhibited by the amino acid sequences Z-IETD and Z-DEVD, respectively. These inhibitors were purchased from R&D Systems and used according to the manufacturer's protocol. Briefly, the inhibitors were added to the cell cultures to a final concentration of 100 M per well. Caspase inhibitors were present throughout the time course. The control was the absence of inhibitors. Caspase 3 activity in the cells was measured after 30 minutes, the time of peak 
Statistical Analysis
Experiments were performed in triplicate. Data were analyzed for significance by one-way ANOVA (SPSS ver. 10; SPSS, Chicago, IL).
RESULTS

Viral Strain Specificity
The HSV-1 viral strains McIntyre, KOS1.1, and McKrae were used to test whether viral strain specificity occurs in our system, as infection with all strains resulted in similar amounts of HSV-1 adsorbed to cells and similar peaks of annexin binding at 1 hour (data not shown). All subsequent experiments were performed using only the McIntyre HSV-1 strain. With regard to assessing the number of cells, there was approximately a 25% increase in cells over the 12-hour experimental period for cells infected with HSV-1, but a rapid decrease in cells (ϳ55%) treated with sorbitol between 8 and 12 hours (Fig. 1) .
Quantification of Active Caspase 8 Protein Levels
Caspase 8 activity was measured over 12 hours (Fig. 1) . Within 30 minutes, active caspase 8 protein levels were significantly higher in HSV-1-infected HCE cells compared with sorbitoltreated or mock-treated HCE cells (P Ͻ 0.05). By 1 hour, active caspase 8 protein levels decreased significantly in HSV-1-infected HCE cells compared with levels at 30 minutes (P Ͻ 0.05). By 2 hours, active caspase 8 protein levels in sorbitoltreated cells had significantly increased compared with sorbitol-treated cells at 1 hour (P Ͻ 0.05), and HSV-1-infected, and mock-treated HCE cells at 2 hours (P Ͻ 0.05). After 2 hours, there were no significant differences among all samples.
Quantification of Active Caspase 9 Protein Levels
Active caspase 9 protein levels in HSV-1-infected cells were not significantly higher than levels in mock-treated cells over time ( Fig. 2A) . Caspase 9 protein levels were significantly higher in sorbitol-treated cells than in HSV-1-infected or mock-treated cells at 8 hours (P Ͻ 0.05). A decrease was observed by 12 hours (P Ͻ 0.05).
Mitochondrial Transmembrane Potential in HCE Cells
Cells infected with HSV-1 produced no change in mitochondrial membrane potential ( 
Quantification of Active Caspase 3 Protein Levels
Caspase 3 activity was measured over 12 hours (Fig. 3) . Within 30 minutes, active caspase 3 protein levels were significantly higher in HSV-1-infected HCE cells than in sorbitol-treated or mock-treated HCE cells (P Ͻ 0.05). Active caspase 3 protein levels decreased significantly in HSV-1-infected HCE cells at 2 hours compared with levels at 30 minutes (P Ͻ 0.05). Sorbitoltreated HCE cells showed a significant peak of activity at 1 hour compared with that at 30 minutes (P Ͻ 0.05), and the level remained high at 2 hours compared with HSV-1-infected cells (P Ͻ 0.05). Between 4 and 12 hours, there were no significant differences among all samples at each time point. Active caspase 3 protein levels in PHCE cells were significantly higher in HSV-1-infected PHCE cells than in sorbitoltreated or mock-treated PHCE cells (P Ͻ 0.05) after 30 minutes (Fig. 3, inset) . Active caspase 3 protein levels decreased significantly in HSV-1-infected PHCE cells at 1 hour compared with HSV-1-infected PHCE cells at 30 minutes (P Ͻ 0.05). Caspase 3 activity of sorbitol-treated PHCE cells increased significantly at 2 hours compared with that at 1 hour (P Ͻ 0.05) and compared with HSV-1-infected and mock-treated PHCE cells at 2 hours (P Ͻ 0.05).
Caspase Inhibition Studies
Caspase 3 activity was measured in the presence of the caspase 8 and 9 inhibitor (Fig. 4) at the peak of caspase 3 activity in HSV-1-infected HCE cells (30 minutes) and sorbitol-treated HCE cells (8 hours). Caspase 3 activity in HSV-1-infected HCE cells in the presence of the caspase 8 inhibitor was significantly reduced compared with the activity in the absence of the inhibitor or in the presence of caspase 9 inhibitors (P Ͻ 0.05). In sorbitol-treated HCE cells, caspase 3 activity was not differ- 
Detection of Caspase Cleavage of Cytokeratin 18
Part of the apoptotic pathway was evaluated by the active caspase 3 or 7-driven cleavage of CK18 (Fig. 5A) . 25 Two peaks of caspase-driven CK18 cleavage were observed in HSV-1-infected HCE cells. The first peak was observed at 30 minutes where the percentage of positively stained cells in HSV-1-infected HCE cells was significantly higher than at 1 hour (P Ͻ 0.05) compared with the other conditions at 30 minutes (P Ͻ 0.05). The second peak was observed at 2 hours when the percentage of positively stained HSV-1-infected HCE cells was significantly higher than at 1 hour or 4 hours (P Ͻ 0.05), as well compared with other conditions at 2 hours (P Ͻ 0.05). There were significant (ϳ10 -15-fold) increases in the percentage of HCE cells treated with sorbitol that stained positively for CK18 at 4, 8, and 12 hours (P Ͻ 0.05) compared with the other treatments. The percentage of positively stained mock-treated HCE did not increase over time.
Detection of Phosphatidylserine Translocation
Initially, transformed HCE cells under various conditions were stained with annexin V and analyzed by flow cytometry over a short time course (0.5, 1, 2, and 4 hours; 
Detection of DNA Condensation by Hoechst 33528 Staining
Sorbitol-treated HCE cells showed a significant increase in the percentage of cells with condensed DNA compared with mock-treated and HSV-1-infected cells at 8 (P Ͻ 0.05) and 12 (P Ͻ 0.05) hours. Within the sorbitol-treated group, a significant increase was observed at 12 hours compared with 8 hours (P Ͻ 0.05; Fig. 5D ). A greater amount of DNA condensation was observed at 12 hours; however, a significant loss of cells (ϳ50%, P Ͻ 0.05) was observed at this time point. HSV-1-infected cells showed no increase in DNA condensation over this 12 hours of the test period (Fig. 6) .
A summary comparing the findings at 0.5 or 2 hours and at 8 hours for the presence of apoptosis markers in cells infected with HSV-1 compared with those challenged with sorbitol is shown in Table 1 . These time points were chosen, as they best illustrate the different response of the cells to the two apoptotic stimuli.
DISCUSSION
This study has demonstrated that HSV-1 infection can induce a proapoptotic response in HCE cells, as shown by activation of caspase 8 and 3, cleavage of cytokeratin 18, and translocation of phosphatidylserine to the outer membrane. The induced apoptotic response did not involve the intrinsic pathway, as there was no caspase 9 induction, nor was there a reduction in mitochondrial membrane potential. There was no terminal apoptotic response as there was no increase in DNA condensation. The response was not considered to be necrotic, as there was only minimal PI staining (in both HSV-1 infected and sorbitol-treated cells), and PI is a stain that can penetrate only cells without intact membrane structures. We have reported that HSV-1 infection of HCE can induce an initial increase (at 1 hour) and then subsequent suppression (4 -8 hours) of mRNA levels for several apoptosis-associated genes such as caspase 8, TNFRp55, TRADD, FAS-associated protein factor, and FADD and that this occurred in HCE cells but not Vero cells. 20 In the current study, we found that the induced proapoptotic response was subsequently downregulated by the virus. 26 It is possible that the small differences in the timing of caspase 3 downregulation between transformed and primary cell lines during HSV-1 infection (Fig. 3) may be due to differences in cell growth rates, which can affect metabolic events within the cell. The suppression of components during HSV-1 infection occurred on the same order as the stimulation. Caspase 8 activity was significantly reduced at 1 hour. Caspase 3 activity and phosphatidylserine translocation were significantly reduced at 2 hours. Finally, CK18 cleavage was suppressed at 4 hours. Stable mitochondrial transmembrane potential and caspase 9 activity were observed during HSV-1 infection (Fig. 2) .
This response is similar but not identical with that produced by HSV-1 infection in (HeLa)-HEp-2 cells, where induction of apoptosis occurred after infection with HSV-1 and in the presence of the protein synthesis inhibitor cycloheximide. 27, 28 HSV-1 appeared to trigger apoptosis independent of de novo protein synthesis before 3 hours after infection, but between 3 and 6 hours after infection, apoptosis was prevented. 25, 29 In our experiments using HCE cells, part of the apoptotic machinery is triggered as early as 30 minutes after infection, but either mammalian cell proteins or viral proteins subsequently shut off this initial apoptotic response. Differences in the apoptotic response triggered by HSV-1 between cell types has been noted previously. 28 During infection of a human promyelocytic leukemia cell line, HSV-1 was unable to reverse or inhibit phosphatidylserine translocation. 25 The exposure of phosphatidyl serine on the surface of apoptotic cells can trigger their specific recognition and removal by macrophages. 22 The apparent reversal of phosphatidylserine translocation in HCE cells infected with HSV-1 may indicate that this effect rescues cells from potential phagocytosis. In a neuronal cell line, others have shown that a mutant HSV-1 activated the apoptotic machinery independent of caspase 3 via the mitochondrial membrane 10 and a similar activation of the intrinsic pathway was seen with (HeLa)-HEp-2 cells. 28 This activation of the intrinsic pathway is directly opposite to that in the current investigation where the extrinsic pathway only is activated. Indeed, Galvan et al. 10 found no evidence that wild-type HSV-1 by itself could activate apoptosis in their neuronal cell line. However, in the (HeLa)-Hep-2 cell line, HSV-1 can induce caspase-dependent apoptosis, but primarily through the intrinsic pathway.
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These differences may result from the use of different cell lines and differing strains of HSV-1 mutants.
In general, the apoptotic response of HCE cells during infection with HSV-1 was distinct to that induced by osmotic shock (sorbitol). Sorbitol treatment appeared to activate the apoptotic response through the intrinsic and extrinsic pathways. This activation of both the intrinsic and extrinsic pathways may explain why there was no effect of caspase 8 or 9 inhibitors on caspase 3 activation during sorbitol treatment. The suppression of caspase activity (caspase 8, 9, and 3) and CK 18 cleavage during sorbitol treatment may result from the many regulatory mechanisms that are present in the cell. 29 This phenomenon appears to be independent of the apoptotic trigger. The reversal of phosphatidylserine translocation that occurred with HSV-1 infection but not osmotic shock could indicate a more specific downregulation of the apoptotic pathway by HSV-1. However, there can be a reversal of the translocation of phosphatidylserine in the absence of HSV-1 infection. 14 The suppression of caspase 8, 9, and 3 activity occurred at a later time in sorbitol-treated HCE cells than in HSV-1-infected HCE cells. The reason for the apparent caspase 9 suppression observed at 12 hours could be the amount of cell death that occurred at this time point.
Viral entry could be the stimulator of the apoptotic pathway. However, Aubert et al. 9 have reported that the initiation of apoptosis by the HSV-1 KOS1.1 strain in Hep-2 cells was not dependent on viral binding to the cells, although that had to induce apoptosis of the cells in the presence of the protein synthesis inhibitor cycloheximide. Further investigations are warranted to determine the molecular nature of the stimulator of HSV-1-induced apoptosis and the inhibitor(s) of the apoptotic response in HCE. It is possible that the cellular protein kinase B (PKB) is responsible for the inhibition of apoptosis. Phosphorylation of PKB occurs early during infection of Hep-2 cells and is responsible for preventing apoptosis in this cell line. 30 Whatever the mechanism, the suppression of the apoptotic response appears to allow continued HCE cell survival and so may be a mechanism for ensuring a viable host cell for viral replication. 
